| | | 54704 | | 17.08.1999 | | Sandoz Pharmaceuticals AG | | 07.03.2005 | | | | | | | | | | | 07.08.60. | | | | 07.08.60. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Estalis 50/140 | transdermale Pflaster | Transdermales Pflaster (Estradiol 0.6 mg, Norethisteroni Acetas 2.7 mg) | G03FA01 | | | 02 | Estalis 50/250 | transdermale Pflaster | Transdermales Pflaster (Estradiol 0.496 mg, Norethisteroni Acetas 4.8 mg) | G03FA01 | |
|
|
